$2.38 0.00 (+0.04%)
11/27/2009 1:00 PM

Keryx Biopharmaceuticals (KERX)

CAPS Rating: 3 out of 5

A biopharmaceutical company focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including diabetes and cancer.

Featured Broker Partners